[1] K.J. Napier, M. Scheerer and S. Misra. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities, World Journal of Gastrointestinal Oncology, 6(5) (2014) 112–120.
[2] J. Guo, G. Teng, G. Zhu, S. He, W. Fang, G. Deng and G. Li. Self-expandable Esophageal Stent Loaded with 125I Seeds: Initial Experience in Patients with Advanced Esophageal Cancer, Radiology, 247(2) (2008) 574–581.
[3] J. Guo, H. Zhu, A. Mao, W. Lv, J. Ji, W. Wang, B. Lv, R. Yang, W. Wu, C.-F. Ni, J. Min, G.-Y. Zhu, L. Chen, M.-L. Zhu, Z.-Y. Dai, P.-F. Liu, J.-P. Gu, W.-X. Ren, R.-H. Shi, G.-F. Xu, S.-C. He, G. Deng and G.-J. Teng. Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial, Lancet Oncology, 15 (2014) 612–619.
[4] W. Zhongmin, H. Xunbo, C. Jun, H. Gang, C. Kemin, L. Yu and L. Fenju. Intraluminal Radioactive Stent Compared with Covered Stent Alone for the Treatment of Malignant Esophageal Stricture. Cardio Vascular and Interventional Radiology, 35 (2012) 351–58.
[5] R. Nath, H. Amols, C. Coffey, D. Duggan, S. Jani, Z. Li, M. Schell, C. Soares, J. Whiting, P. E. Cole, I. Crocker and R. Schwartz, Intravascular brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 60, Medical Physics, 26(2) (1999) 119–152.
[6] S.T. Chiu-Tsao, D.R. Schaart, C.G. Soares and R. Nath. Dose calculation formalisms and consensus dosimetry parameters for intravascular brachytherapy dosimetry: Recommendations of the AAPM Therapy Physics Committee Task Group No. 149, Medical Physics, 34(11) (2007) 4126–4158.
[7] V. Lohrabian, S. Sheibani, M.R. Aghamiri, B. Ghozati, H. Pourbeigi and H.R. Baghani. Determination of Dosimetric Characteristics of IrSeed 125I Brachytherapy Source, Iranian Journal of Medical Physics, 10(3) (2013) 109–117.
[8] M.J. Rivard, B.M. Coursey, L.A. DeWerd, W.F. Hanson, M.S. Huq, G.S. Ibbott, M.G. Mitch, R. Nath and J.F. Williamson. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations, AAPM-TGU1, 31(3) (2004) 633–674.
[9] Z. Chen, Y. Chen and W. Li. Preparation of 1251 Radioactive Covered Metal Stent, Journal of Isotopes, 27(2) (2014) 109–115.
[10] E.S. Kim, S.W. Jeon, S.Y. Park, C.M. Cho, W.Y. Tak, Y.O. Kweon, S.K. Kim and Y.H. Choi. Comparison of double-layered and covered Niti-S stents for palliation of malignant dysphagia, Journal of Gastroenterology and Hepatology, 24 (2009) 114–119.
[11] S. Agostinelliae, J. Allisonas, K. Amakoe, J. Apos, H. Araujoaj, P. Arcel, M. Asaig, D. Axeni, S. Banerjeebi, G. Barrandan, F. Behnerl, L. Bellag, J. Boudreaubd, L. Brogliaar, A. Brunengoc, H. Burk, S. Chauviebj, J. Chumah, R. Chytraceka, G. Cooperm, G. Cosmoa, P. Degtyarenkod, A. Dell’Acquaa, G. Dep, D. Dietrichaf, R. Enamiab, A. Feliciellobj, C. Fer, H. Fesefeldtl, G. Folgera, F. Foppianoac, A. Forti, S. Garelliac, S. Giania, R. Giannitrapanibo, D. Gi and et al. Geant4-a simulation toolkit, Nuclear Instruments and Methods in Physics Research A, 506 (2003) 250–303.
[12] H.M. Yu, H.T. Zhang, B.Y. Ding, A.X. Sui, J. Wang and J. Wu. Esophageal stent covered with radioactive 125I seeds arranged at different distance: dosimetric comparison study Interventional Radiology, 24(4) (2015) 338–341.
[13] L. Gaspar, S. Nag, A. Herskovic, R. Mantravadi and B. Speiser. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer, International Journal of Radiation Oncology*Biology*Physics, 38(1) (1997) 127–132.